Jefferies Financial Group increased their price target on Cogent Biosciences from $23.00 to $28.00 a...
Leerink Partners raised their target price on Cogent Biosciences from $16.00 to $18.00 and gave the ...
Cogent Biosciences said its experimental drug reduced the symptoms of a chronic immune disorder call...
Cogent Biosciences said it’s working on an FDA submission for its systemic mastocytosis (SM) drug af...